$OPGN
OPGEN INC Stock $opgn

$opgn Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000182912624004635 Filed on July 08, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2024 Q1
Revenue		$28.00K	$168.1K
YoY Change		-96.2%	-81.59%
Cost Of Revenue			$73.24K
YoY Change			-87.64%
Gross Profit			$94.91K
YoY Change			-70.44%
Gross Profit Margin			56.45%
Selling, General & Admin	$783.4K	$1.594M	$1.771M
YoY Change	-66.96%	-55.54%	-48.68%
% of Gross Profit			1865.6%
Research & Development	$488.00	$22.96K	$25.86K
YoY Change	-99.96%	-98.35%	-98.57%
% of Gross Profit			27.24%
Depreciation & Amortization			$138.00
YoY Change			-99.96%
% of Gross Profit			0.15%
Operating Expenses	$783.9K	$1.617M	$1.797M
YoY Change	-78.06%	-67.49%	-65.86%
Operating Profit	-$783.9K	-$1.547M	-$1.703M
YoY Change	-78.02%	-69.99%	-66.41%
Interest Expense	$3.238K	$1.079K
YoY Change	-99.18%	-99.84%
% of Operating Profit
Other Income/Expense, Net	$9.715M	-$29.04K	$2.089M
YoY Change	-2053.42%	-95.67%	-413.47%
Pretax Income	$8.931M	-$1.576M	$386.0K
YoY Change	-319.82%	-72.95%	-106.73%
Income Tax
% Of Pretax Income
Net Earnings	$8.931M	-$1.576M	$386.0K
YoY Change	-319.82%	-72.95%	-106.73%
Net Earnings / Revenue		-5629.82%	229.58%
Basic Earnings Per Share	$1.43		$0.21
Diluted Earnings Per Share	$1.35		$0.21
COMMON SHARES
Basic Shares Outstanding	1.349M shares	1.344M shares	1.284M shares
Diluted Shares Outstanding	6.604M shares		1.332M shares

Balance Sheet

Concept	2024 Q3	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments			$267.5K
YoY Change			-96.2%
Cash & Equivalents	$1.633M	$168.1K	$267.5K
Short-Term Investments
Other Short-Term Assets			$227.1K
YoY Change			-84.4%
Inventory
Prepaid Expenses
Receivables	$24.40K	$25.40K	$37.97K
Other Receivables			$0.00
Total Short-Term Assets	$3.217M	$572.8K	$532.6K
YoY Change	-6.87%	-92.08%	-95.04%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.117M	$1.155M	$0.00
YoY Change	-70.76%	-69.99%	-100.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$302.3K	$302.3K	$302.3K
YoY Change	-38.57%	-39.17%	-39.19%
Total Long-Term Assets	$2.252M	$2.297M	$2.438M
YoY Change	-84.66%	-84.9%	-84.54%
TOTAL ASSETS
Total Short-Term Assets	$3.217M	$572.8K	$532.6K
Total Long-Term Assets	$2.252M	$2.297M	$2.438M
Total Assets	$5.470M	$2.870M	$2.970M
YoY Change	-69.84%	-87.21%	-88.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$103.9K	$128.4K	$191.6K
YoY Change	-88.52%	-34.26%	-28.15%
Accrued Expenses	$89.17K	$565.3K	$378.6K
YoY Change	-92.97%	-45.81%	-73.64%
Deferred Revenue			$8.571K
YoY Change			-81.37%
Short-Term Debt			$0.00
YoY Change			-100.0%
Long-Term Debt Due		$11.10M	$10.92M
YoY Change		20.76%	120.2%
Total Short-Term Liabilities	$589.8K	$12.60M	$11.70M
YoY Change	-95.27%	1.48%	35.49%
LONG-TERM LIABILITIES
Long-Term Debt			$0.00
YoY Change			-100.0%
Other Long-Term Liabilities			$1.981M
YoY Change			1433.46%
Total Long-Term Liabilities			$1.981M
YoY Change			1433.46%
TOTAL LIABILITIES
Total Short-Term Liabilities	$589.8K	$12.60M	$11.70M
Total Long-Term Liabilities			$1.981M
Total Liabilities	$2.484M	$14.54M	$13.68M
YoY Change	-83.93%	-6.66%	-21.07%
SHAREHOLDERS EQUITY
Retained Earnings	-$297.9M	-$306.8M	-$305.1M
YoY Change	3.26%	7.87%	9.53%
Common Stock	$100.7K	$13.49K	$13.04K
YoY Change	0.55%	-80.64%	-76.28%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.986M	$2.500M	-$10.71M
YoY Change
Total Liabilities & Shareholders Equity	$5.470M	$2.870M	$2.970M
YoY Change	-69.84%	-87.21%	-88.8%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	$8.931M	-$1.576M	$386.0K
YoY Change	-319.82%	-72.95%	-106.73%
Depreciation, Depletion And Amortization			$138.00
YoY Change			-99.96%
Cash From Operating Activities			-$1.084M
YoY Change			-78.16%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities			$199.7K
YoY Change			-95.79%
NET CHANGE
Cash From Operating Activities			-$1.084M
Cash From Investing Activities
Cash From Financing Activities			$199.7K
Net Change In Cash			-$884.3K
YoY Change			121.51%
FREE CASH FLOW
Cash From Operating Activities			-$1.084M
Capital Expenditures
Free Cash Flow			-$1.084M
YoY Change			-79.52%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset		usd
CY2023Q4	opgn	Indemnification Assets IndemnificationAssets		usd
CY2024Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent		usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax		usd
CY2023Q1	opgn	Gain On Lease Indemnification GainOnLeaseIndemnification		usd
CY2024Q1	us-gaap	Interest Expense InterestExpense		usd
CY2024Q1	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss		usd
CY2023Q1	opgn	Change In Fair Value Of Eib Loan Guaranty ChangeInFairValueOfEibLoanGuaranty		usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	opgn	Net Income Loss Allocated To Preferred Stockholders NetIncomeLossAllocatedToPreferredStockholders		usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent		usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures		usd
CY2023Q1	opgn	Stock Issued During Period Share Cancellation Value StockIssuedDuringPeriodShareCancellationValue		usd
CY2024Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures		usd
CY2024Q1	opgn	Reclassification Of Preferred Stock Par Value To Additional Paidin Capital ReclassificationOfPreferredStockParValueToAdditionalPaidinCapital		usd
CY2024Q1	us-gaap	Accretion Expense AccretionExpense		usd
CY2023Q1	opgn	Gain On Lease Indemnification GainOnLeaseIndemnification		usd
CY2023Q1	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount		usd
CY2024Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2023Q1	opgn	Change In Fair Value Of Eib Loan ChangeInFairValueOfEibLoan		usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants		usd
CY2024Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt		usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations		usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2024Q1	opgn	Rightofuse Assets Acquired Through Operating Leases RightofuseAssetsAcquiredThroughOperatingLeases		usd
CY2024Q1	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves		usd
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves		usd
CY2024Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves		usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves		usd
CY2024Q1	us-gaap	Inventory Net InventoryNet		usd
CY2023Q4	us-gaap	Inventory Net InventoryNet		usd
CY2023Q1	opgn	Net Income Allocated To Preferred Stock Basic NetIncomeAllocatedToPreferredStockBasic		shares
CY2023Q1	opgn	Net Income Allocated To Preferred Stock Diluted NetIncomeAllocatedToPreferredStockDiluted		shares
CY2023Q1	opgn	Dilutive Effect Of Stock Purchase Warrants DilutiveEffectOfStockPurchaseWarrants		shares
CY2024Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount		usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount		usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt		usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt		usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2024Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset		usd
CY2024Q1	opgn	Lease Right Of Use Asset LeaseRightOfUseAsset		usd
CY2024Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent		usd
CY2024Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent		usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent		usd
CY2024Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent		pure
CY2024Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability		usd
CY2023Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability		usd
CY2024Q1	opgn	Operating Leases OperatingLeases		usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	138	usd
CY2024Q1	opgn	Indemnification Assets IndemnificationAssets	2135545	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	302262	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	302262	usd
CY2024Q1	us-gaap	Assets Assets	2970380	usd
CY2023Q4	us-gaap	Assets Assets	1882274	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	191575	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	111149	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	47828	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	127601	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	378586	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	135476	usd
CY2024Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	8571	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	25926	usd
CY2024Q1	opgn	Eib Loan Guaranty EibLoanGuaranty	10920451	usd
CY2023Q4	opgn	Eib Loan Guaranty EibLoanGuaranty	10873867	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	280	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	154117	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	147943	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	11701128	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11422242	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1981428	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2021616	usd
CY2024Q1	us-gaap	Liabilities Liabilities	13682556	usd
CY2023Q4	us-gaap	Liabilities Liabilities	13443858	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1303739	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1303739	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1282686	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1282686	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	13037	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	12827	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	294380054	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	293991529	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-305107269	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-305493302	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-75138	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-10712176	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-11561584	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2970380	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1882274	usd
CY2024Q1	us-gaap	Revenues Revenues	168149	usd
CY2023Q1	us-gaap	Revenues Revenues	913444	usd
CY2024Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	73236	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	592378	usd
CY2024Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	1575	usd
CY2023Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	128306	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	25856	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1812831	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1642054	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2423953	usd
CY2024Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	128646	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1026087	usd
CY2024Q1	us-gaap	Costs And Expenses CostsAndExpenses	1871367	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	5983555	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1703218	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-5070111	usd
CY2024Q1	opgn	Interest And Other Income Net InterestAndOtherIncomeNet	9	usd
CY2023Q1	opgn	Interest And Other Income Net InterestAndOtherIncomeNet	30106	usd
CY2024Q1	opgn	Gain On Lease Indemnification GainOnLeaseIndemnification	2135545	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	617298	usd
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	281	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-91994	usd
CY2023Q1	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	12694	usd
CY2024Q1	opgn	Change In Fair Value Of Eib Loan Guaranty ChangeInFairValueOfEibLoanGuaranty	46584	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2089251	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-666492	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	386033	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5736603	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	386033	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-5736603	usd
CY2024Q1	opgn	Net Income Loss Allocated To Preferred Stockholders NetIncomeLossAllocatedToPreferredStockholders	-113225	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	272808	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5736603	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.212
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-12.53
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.207
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-12.53
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1284305	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	457727	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1331578	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	457727	shares
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	386033	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-5736603	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	153067	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	386033	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5583536	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	7575548	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	211122	usd
CY2023Q1	opgn	Offering Of Common Stock And Warrants Net Of Issuance Costs OfferingOfCommonStockAndWarrantsNetOfIssuanceCosts	6974050	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	153067	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-5736603	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	9177184	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-11561584	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	188237	usd
CY2024Q1	opgn	Offering Of Preferred Stock And Warrants Net Of Issuance Costs OfferingOfPreferredStockAndWarrantsNetOfIssuanceCosts	200000	usd
CY2024Q1	opgn	Elimination Of Translation Adjustments Of Previously Dissolved Subsidiaries EliminationOfTranslationAdjustmentsOfPreviouslyDissolvedSubsidiaries	75138	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	386033	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-10712176	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	386033	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-5736603	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	138	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	350452	usd
CY2023Q1	us-gaap	Accretion Expense AccretionExpense	456679	usd
CY2024Q1	opgn	Gain On Lease Indemnification GainOnLeaseIndemnification	2135545	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	188237	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	211122	usd
CY2024Q1	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	-13240	usd
CY2023Q1	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	256814	usd
CY2024Q1	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	-75138	usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-12694	usd
CY2024Q1	opgn	Change In Fair Value Of Eib Loan ChangeInFairValueOfEibLoan	46584	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-65348	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	142177	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-13240	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	195029	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-97623	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-3498	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	80426	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-157139	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	129323	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	100388	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-17355	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-97929	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1084050	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4962618	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	330446	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-330446	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6974050	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants	200000	usd
CY2023Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	2229560	usd
CY2024Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	280	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	841	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	199720	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4743649	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	150186	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-884330	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-399229	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1454085	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7935659	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	569755	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7536430	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	56320	usd
CY2023Q1	opgn	Rightofuse Assets Acquired Through Operating Leases RightofuseAssetsAcquiredThroughOperatingLeases	801321	usd
CY2024Q3	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	8000000	usd
CY2023Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.01
CY2023Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1089274	shares
CY2023Q4	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	7.785
CY2023Q4	opgn	Additional Consideration Required AdditionalConsiderationRequired	0.25
CY2023Q4	opgn	Shares Exercised SharesExercised	200000	shares
CY2024Q1	opgn	Gross Proceeds From2023 Warrant Inducement GrossProceedsFrom2023WarrantInducement	2057000.000	usd
CY2023Q4	us-gaap	Investments Investments	250000	usd
CY2023Q4	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	1000000.0	usd
CY2023Q2	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	3000000
CY2023Q2	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	1000000
CY2023Q2	opgn	Gross Proceeds From Equity Transaction GrossProceedsFromEquityTransaction	3500000	usd
CY2023Q2	opgn	Net Proceeds Issuance From Warrants NetProceedsIssuanceFromWarrants	3000000.0	usd
CY2023Q4	opgn	Payment Of Additional Consideration Price PaymentOfAdditionalConsiderationPrice	0.25
CY2023Q2	opgn	Number Of Warrants Repriced NumberOfWarrantsRepriced	639691	shares
CY2023Q2	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	7.785
CY2023Q2	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2023Q2	opgn	Increase In Fair Value Resulting From Warrant Modification IncreaseInFairValueResultingFromWarrantModification	300000	usd
CY2024Q1	opgn	Common Shares Exercised CommonSharesExercised	200000	shares
CY2024Q1	opgn	Gross Proceeds From2023 Warrant Inducement GrossProceedsFrom2023WarrantInducement	2057000.000	usd
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	26.50
CY2023Q1	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	7.785
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	2500	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	2500	usd
CY2024Q1	opgn	Accumulated Other Comprehensive Loss AccumulatedOtherComprehensiveLoss	75100	usd
CY2024Q1	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	-75138	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_842_eus-gaap--UseOfEstimates_zkLAn0liLiJ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zcvvGcZjJrWj">Use of estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In preparing financial statements in conformity with GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. In the accompanying unaudited condensed consolidated financial statements, estimates are used for, but not limited to, liquidity assumptions, revenue recognition, stock-based compensation, allowances for doubtful accounts and inventory obsolescence, discount rates used to discount unpaid lease payments to present values, valuation of derivative financial instruments measured at fair value on a recurring basis, and deferred tax assets and liabilities and related valuation allowance. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2024Q1	us-gaap	Restricted Cash RestrictedCash	302262	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	302262	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	267493	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1151823	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7039375	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7440030	usd
CY2024Q1	us-gaap	Restricted Cash RestrictedCash	302262	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	302262	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	497055	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	495629	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	569755	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1454085	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7536430	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7935659	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2024Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1267565	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1280805	usd
CY2024Q1	us-gaap	Inventory Gross InventoryGross	1267565	usd
CY2023Q4	us-gaap	Inventory Gross InventoryGross	1280805	usd
CY2024Q1	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	-1267565	usd
CY2023Q4	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	-1280805	usd
CY2024Q1	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	1231874	usd
CY2024Q1	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	849243	usd
CY2023Q1	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	0	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	186377	usd
CY2023Q1	opgn	Research And Development Expense From Government Grant ResearchAndDevelopmentExpenseFromGovernmentGrant	133938	usd
CY2024Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2024Q1	opgn	Tax Benefit Percentage TaxBenefitPercentage	0.50	pure
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	241110447	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	232682072	usd
CY2024Q1	opgn	Net Income Loss Basic NetIncomeLossBasic	386033	usd
CY2023Q1	opgn	Net Income Loss Basic NetIncomeLossBasic	-5736603	usd
CY2024Q1	opgn	Net Income Loss Diluted NetIncomeLossDiluted	386033	usd
CY2023Q1	opgn	Net Income Loss Diluted NetIncomeLossDiluted	-5736603	usd
CY2024Q1	opgn	Net Income Allocated To Preferred Stock Basic NetIncomeAllocatedToPreferredStockBasic	-113225	shares
CY2024Q1	opgn	Net Income Allocated To Preferred Stock Diluted NetIncomeAllocatedToPreferredStockDiluted	-110396	shares
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	272808	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5736603	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	275637	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-5736603	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	1284305	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	457727	shares
CY2024Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1284305	shares
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	457727	shares
CY2024Q1	opgn	Dilutive Effect Of Stock Purchase Warrants DilutiveEffectOfStockPurchaseWarrants	47273	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1331578	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	457727	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.212
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-12.53
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.207
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-12.53
CY2024Q1	us-gaap	Weighted Average Limited Partnership Units Outstanding Diluted WeightedAverageLimitedPartnershipUnitsOutstandingDiluted	1100000	shares
CY2023Q1	us-gaap	Weighted Average Limited Partnership Units Outstanding Diluted WeightedAverageLimitedPartnershipUnitsOutstandingDiluted	700000	shares
CY2024Q1	us-gaap	Revenues Revenues	168149	usd
CY2023Q1	us-gaap	Revenues Revenues	913444	usd
CY2024Q1	us-gaap	Revenues Revenues	168149	usd
CY2023Q1	us-gaap	Revenues Revenues	913444	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	142061	usd
CY2023	us-gaap	Contract With Customer Asset Purchase ContractWithCustomerAssetPurchase	74109	usd
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-144196	usd
CY2023	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	-46048	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	25926	usd
CY2024Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-12525	usd
CY2024Q1	opgn	Refunded To Customers In Current Period RefundedToCustomersInCurrentPeriod	-4830	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	8571	usd
CY2023	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	1231874	usd
CY2023	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	849243	usd
CY2024Q1	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	10920451	usd
CY2023Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	10873867	usd
CY2024Q1	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	10920451	usd
CY2023Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	10873867	usd
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	10920451	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	10873867	usd
CY2017Q2	us-gaap	Accounts Payable Interest Bearing Interest Rate AccountsPayableInterestBearingInterestRate	0.04	pure
CY2019Q2	us-gaap	Escrow Deposit Disbursements Related To Property Acquisition1 EscrowDepositDisbursementsRelatedToPropertyAcquisition1	5000000.0
CY2019Q2	us-gaap	Line Of Credit Facility Increase Decrease For Period Net LineOfCreditFacilityIncreaseDecreaseForPeriodNet	5000000.0
CY2022Q2	us-gaap	Payments For Loans PaymentsForLoans	700000
CY2023Q2	opgn	Aggrement Amount Paid AggrementAmountPaid	1000000
CY2024Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	0	usd
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	617298	usd
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1303739	shares
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q1	us-gaap	Preferred Stock Share Subscriptions PreferredStockShareSubscriptions	6999000	shares
CY2024Q1	opgn	Preferred Stock Share Undesignated PreferredStockShareUndesignated	6999000	shares
CY2023Q1	opgn	Exercise Price Of Common Warrants ExercisePriceOfCommonWarrants	26.50
CY2023Q1	opgn	Exercise Price Of Pre Funded Warrants ExercisePriceOfPreFundedWarrants	0.10
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	7.785
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	60500	shares
CY2023Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.01
CY2023Q2	opgn	Prefunded Warrants In Shares PrefundedWarrantsInShares	389083	shares
CY2023Q2	opgn	Common Warrants Issued CommonWarrantsIssued	449583	shares
CY2023Q2	opgn	Price Per Share Of Common Stock And Accompanying Common Warrant PricePerShareOfCommonStockAndAccompanyingCommonWarrant	7.785
CY2023Q2	opgn	Price Per Share Of Prefunded Warrant And Common Warrant PricePerShareOfPrefundedWarrantAndCommonWarrant	7.685
CY2023Q2	opgn	Gross Proceeds From Equity Transaction GrossProceedsFromEquityTransaction	3500000	usd
CY2023Q2	opgn	Net Proceeds From Issuance Of Common Stock NetProceedsFromIssuanceOfCommonStock	3000000.0	usd
CY2023Q2	opgn	Exercise Price Of Common Warrants ExercisePriceOfCommonWarrants	7.785
CY2023Q2	opgn	Number Of Repriced Warrants To Purchase Shares NumberOfRepricedWarrantsToPurchaseShares	639691	shares
CY2023Q4	opgn	Number Of Warrants Exercised In Shares NumberOfWarrantsExercisedInShares	200000	shares
CY2023Q4	opgn	Gross Proceeds For Warrant Inducement GrossProceedsForWarrantInducement	2057000.000	usd
CY2023Q4	opgn	Shares Of Series D Preferred Stock For Sale SharesOfSeriesDPreferredStockForSale	1000
CY2023Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.01
CY2023Q4	us-gaap	Share Price SharePrice	4.09
CY2023Q4	opgn	Affiliates Holding Percentage AffiliatesHoldingPercentage	0.1999	pure
CY2023Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.01
CY2023Q4	opgn	Warrants Available For Inducement In Shares WarrantsAvailableForInducementInShares	1089274	shares
CY2023Q4	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	7.785
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	1	pure
CY2023Q4	opgn	Number Of Warrants Exercised In Shares NumberOfWarrantsExercisedInShares	200000	shares
CY2023Q4	opgn	Gross Proceeds For Warrant Inducement GrossProceedsForWarrantInducement	2057000.000	usd
CY2024Q1	opgn	Allocated Share Based Compensation Expense Benefit AllocatedShareBasedCompensationExpenseBenefit	188237	usd
CY2023Q1	opgn	Allocated Share Based Compensation Expense Benefit AllocatedShareBasedCompensationExpenseBenefit	211122	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	83	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	88	shares
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	6913	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	1095517	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	1095517	shares
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	138	usd
CY2023Q4	opgn	Lease Right Of Use Asset LeaseRightOfUseAsset	138	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	154117	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	147943	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	280	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1981428	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2021616	usd
CY2024Q1	opgn	Lease Liability LeaseLiability	2135545	usd
CY2023Q4	opgn	Lease Liability LeaseLiability	2169839	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	270377	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	368179	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	378279	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	388682	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	399388	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	1338300	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3143205	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1007660	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	2135545	usd
CY2024Q1	us-gaap	Lease Cost LeaseCost	58634	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	138626	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y10M24D
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.100	pure
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	58496	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	137797	usd
CY2024Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	280	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	841	usd
CY2023Q1	opgn	Operating Leases OperatingLeases	801321	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	2500000	usd

Files In Submission

Name	View Source	Status
0001829126-24-004635-index-headers.html	Edgar Link	pending
0001829126-24-004635-index.html	Edgar Link	pending
0001829126-24-004635.txt	Edgar Link	pending
0001829126-24-004635-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
opgeninc_10q.htm	Edgar Link	pending
opgeninc_ex31-1.htm	Edgar Link	pending
opgeninc_ex32-1.htm	Edgar Link	pending
opgn-20240331.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
opgn-20240331_cal.xml	Edgar Link	unprocessable
opgn-20240331_lab.xml	Edgar Link	unprocessable
opgn-20240331_def.xml	Edgar Link	unprocessable
opgn-20240331_pre.xml	Edgar Link	unprocessable
opgeninc_10q_htm.xml	Edgar Link	completed
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OPGN
OPGEN INC Stock $opgn

2024 Q3 Form 10-Q Financial Statement

#000182912624004635 Filed on July 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPGN OPGEN INC Stock $opgn

2024 Q3 Form 10-Q Financial Statement

#000182912624004635 Filed on July 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPGN
OPGEN INC Stock $opgn